Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Jun 3:cebp.0145.2019. doi: 10.1158/1055-9965.EPI-19-0145

Table 3.

Geometric Mean Serum PSA Concentration (ng/mL) and 95% Confidence Intervals by Abnormal versus Normal Fibrosis Scores Overall and By Race/Ethnicity Among Men 40 Years and Older, NHANES 2001–2010

Overall White (non-Hispanic) Black (non-Hispanic) Mexican-American
/Other Hispanic
APRI
Normal Abnormalc Normal Abnormal Normal Abnormal Normal Abnormal
Model 1a 0.96 0.75 0.97 0.69 1.00 0.86 0.95 0.89
(0.94,0.99) (0.64,0.88) (0.94,1.00) (0.55,0.86) (0.95,1.06) (0.66,1.12) (0.89,1.01) (0.72,1.09)
Model 2b 0.96 0.76 0.97 0.71 1.00 0.82 0.95 0.9
(0.94,0.99) (0.64,0.89) (0.94,1.00) (0.57,0.89) (0.95,1.07) (0.63,1.07) (0.89,1.01) (0.72,1.13)
FIB4
Normal Abnormal Normal Abnormal Normal Abnormal Normal Abnormal
Model 1 0.96 0.81 0.97 0.79 1.00 0.92 0.95 0.88
(0.94,0.99) (0.70,0.93) (0.94,1.00) (0.66,0.95) (0.94,1.06) (0.72,1.18) (0.89,1.01) (0.67,1.15)
Model 2 0.96 0.80 0.97 0.79 1.00 0.89 0.95 0.88
(0.94,0.99) (0.70,0.93) (0.94,1.00) (0.66,0.95) (0.95,1.06) (0.69,1.13) (0.89,1.01) (0.66,1.17)
NFS
Normal Abnormal Normal Abnormal Normal Abnormal Normal Abnormal
Model 1 0.97 0.77 0.97 0.78 1.00 0.98 0.95 0.82
(0.95,1.00) (0.71,0.84) (0.94,1.00) (0.71,0.86) (0.94,1.06) (0.79,1.22) (0.89,1.01) (0.66,1.01)
Model 2 0.97 0.83 0.97 0.85 1.00 1.02 0.95 0.84
(0.94,0.99) (0.77,0.90) (0.94,1.00) (0.77,0.94) (0.94,1.06) (0.81,1.29) (0.89,1.01) (0.69,1.04)
a

Model 1 adjusted for age and race, numbers with bold font implies p<0.05;

b

Model 2 adjusted for the age, race, BMI category, diabetes status, alcohol drinking status and smoking status;

c

Cutpoint for abnormal liver fibrosis equates to advanced fibrosis (APRI >1, FIB-4 >2.67 and NFS >0.676).